SXTP — 60 Degrees Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
- $4.06m
- $10.95m
- $1.41m
Annual cashflow statement for 60 Degrees Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.26 | -6.18 | -3.81 | -7.96 | -7.37 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.684 | 1.83 | -1.18 | 2.06 | 0.442 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.9 | 3.31 | 0.405 | 0.193 | -0.005 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.649 | -1.01 | -4.54 | -5.65 | -6.85 |
| Capital Expenditures | -0.035 | -0.06 | -0.116 | -0.181 | -0.218 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -1.71 | 0.473 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.035 | -0.06 | -0.116 | -1.89 | 0.255 |
| Financing Cash Flow Items | 0 | 0.117 | -0.15 | 3.41 | -0.018 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.611 | 1.22 | 6.47 | 7.05 | 6.44 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.076 | 0.149 | 1.88 | -0.483 | -0.149 |